Home › NDC Lookup › RxCUI directory › RxCUI 866103

24 HR paliperidone 1.5 MG Extended Release Oral Tablet — RxCUI 866103

RxNorm drug concept · Semantic clinical drug
RxCUI 866103 Semantic clinical drug · SCD ● Current RxNorm concept 53 FDA products 71 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI866103
Official name24 HR paliperidone 1.5 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspaliperidone 1.5 MG 24HR Extended Release Oral Tablet
FDA products mapped53
Package NDCs mapped71
Reported Medicaid activity (SDUD)320,540 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Paliperidone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Paliperidone is an antipsychotic medication used to treat schizophrenia and schizoaffective disorder. It works by calming overactive signals in the brain — specifically blocking ce...
  • What exactly does paliperidone do — why did my doctor prescribe it?
  • Yes — swallow the tablet whole. Don't chew it, crush it, or split it. The tablet is specially designed to release the medication slowly over the day, and breaking it would release...
  • I've been prescribed the tablet form. Is there anything special about how I take it?
📖 Read our full Paliperidone guide →

🕸️ Concept Web — How 24 HR paliperidone 1.5 MG Extended Release Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR paliperidone 1.5 MG Extended Release Oral Tablet RxCUI 866103

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Paliperidone 679314
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Invega 686438
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Paliperidone Extended Release Oral Tablet 672566
    • Paliperidone Oral Product 1160709
    • Paliperidone Pill 1160710
    • Paliperidone Extended Release Oral Tablet [Invega] 686440
    • Invega Oral Product 1173451
    • Invega Pill 1173452
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Paliperidone 1.5 MG SCDC · 859995
  • Paliperidone Extended Release Oral Tablet SCDF · 672566
  • Paliperidone Oral Product SCDG · 1160709
  • Paliperidone Pill SCDG · 1160710

Brand-Name Concepts

📦 FDA Products & Package NDCs

53 products · 71 package NDCs
71 package NDCs map to RxCUI 866103 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65162-0282-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-282-03) Paliperidone Amneal Pharmaceuticals LLC 2019-09-24
65162-0282-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-282-09) Paliperidone Amneal Pharmaceuticals LLC 2019-09-24
65162-0283-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-283-03) Paliperidone Amneal Pharmaceuticals LLC 2019-09-24
65162-0283-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-283-09) Paliperidone Amneal Pharmaceuticals LLC 2019-09-24
69367-0432-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-432-30) Paliperidone Westminster Pharmaceuticals, LLC 2025-12-09
69367-0433-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-433-30) Paliperidone Westminster Pharmaceuticals, LLC 2025-12-09
69367-0434-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-434-30) Paliperidone Westminster Pharmaceuticals, LLC 2025-12-09
69367-0435-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-435-30) Paliperidone Westminster Pharmaceuticals, LLC 2025-12-09
72162-2648-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2648-3) Paliperidone Bryant Ranch Prepack 2026-05-27
72658-1253-01 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1253-1) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1253-02 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1253-2) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1253-03 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1253-3) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1254-01 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1254-1) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1254-02 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1254-2) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1254-03 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1254-3) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1255-01 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1255-1) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1255-02 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1255-2) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1255-03 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1255-3) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1256-01 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1256-1) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1256-02 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1256-2) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
72658-1256-03 500 TABLET, EXTENDED RELEASE in 1 PACKAGE (72658-1256-3) PALIPERIDONE Eskayef Pharmaceuticals Limited 2025-10-02
Observed labelers: Eskayef Pharmaceuticals Limited (12) · Amneal Pharmaceuticals LLC (8) · Sun Pharmaceutical Industries, Inc. (8) · Janssen Pharmaceuticals, Inc. (6) · Ajanta Pharma USA Inc. (4) · Alembic Pharmaceuticals Inc. (4) · +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.